Puma Biotechnology, Inc. (PBYI)

6.21 -0.21 (-3.27%) USD  |  NASDAQ  |  Mar 03, 16:00
6.205 0.00 (0.00%) After-Hours: 20:00
More

Puma Biotechnology Research and Development Expense (Annual) : 62.07M for Dec. 31, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for PBYI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Assertio Holdings, Inc. 3.822M
Pfizer Inc. 10.25B
Rigel Pharmaceuticals, Inc. 23.38M
CorMedix, Inc. 3.942M
BioXcel Therapeutics, Inc. 29.19M